Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCAPI1072 Diphenhydramine HCl (Benadryl)
Diphenhydramine HCl (Benadryl)
More description
DC9834 Dioscin Featured
Dioscin(CCRIS 4123; Collettiside III) is a natural steroid saponin derived from several plants, showing potent anti-cancer effect against a variety of tumor cell lines.
More description
DC8722 Dimethoxycurcumin(DiMC) Featured
Dimethoxycurcumin is an analog of curcumin obtained by methylation of both free phenolic groups in the parent compound.
More description
DC10791 DIM-C-pPhOH(CDIM8) Featured
DIM-C-pPhOH is a Nur77 Antagonist. DIM-C-pPhOH inhibits lung cancer cell and tumor growth in a metastasis model.
More description
DC8274 Dihydroethidium Featured
Dihydroethidium(Hydroethidine; PD-MY 003) is a superoxide indicator; exhibits blue-fluorescence in the cytosol until oxidized, where it intercalates within the cell's DNA, staining its nucleus a bright fluorescent red.
More description
DC9760 Dihexa (PNB-0408) Featured
Dihexa is an oligopeptide drug that binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at its receptor, c-Met.
More description
DCAPI1032 Dichlorphenamide (Diclofenamide) Featured
Dichlorphenamide (Diclofenamide)
More description
DCAPI1025 Dexamethasone Featured
Dexamethasone is a potent synthetic member of the glucocorticoid class of steroid drugs used as an anti-inflammatory and immunosuppressant.
More description
DC11055 Desmethyl dabrafenib Featured
Desmethyl dabrafenib (GSK2167542, Dabrafenib metabolite M8) is the desmethyl- metabolic byproduct of Dabrafenib, ameliorates developmental pathologies of Kabuki Syndrome in vivo..
More description
DC10458 Delafloxacin(ABT-492) Featured
Delafloxacin (RX-3341, ABT-492) is a fluoroquinolone antibiotic agent.
More description
DC9337 Deguelin Featured
Deguelin, a naturally occurring rotenoid, is known to be an Akt inhibitor and to have an anti-tumor effect on several cancers; decrease levels of phosphorylated Akt.
More description
DC11332 Degarelix (acetate) Featured
Degarelix is a synthetic gonadotropin-releasing hormone receptor (GNRHR) antagonist (IC50 = 3 nM in HEK293 cells expressing the human receptor).
More description
DC4193 Decitabine Featured
Decitabine is a potent inhibitor of DNA methylation with IC50 of 438 nM and 4.38 nM in HL-60 and KG1a cells, respectively.
More description
DC7398 DDR1-IN-1 Featured
DDR1-IN-1 is a potent and selective DDR1 receptor tyrosine kinase inhibitor with IC50/EC50 of 105 nM/87 nM; 4-fold less potent for DDR2 (IC50= 413 nM).
More description
DC12554 DC661 Featured
DC661 (DC-661) is a novel dimeric chloroquine (CQ) that is capable of deacidifying the lysosome and inhibiting autophagy significantly better than HCQ, targets palmitoyl-protein thioesterase 1 (PPT1).
More description
DC21382 EIDD-1931(NHC) Featured
EIDD-1931 (β-d-N4-Hydroxycytidine, NHC) inhibits both murine hepatitis virus (MHV) (EC50 of 0.17 μM) and Middle East respiratory syndrome CoV (MERS-CoV) (EC50 of 0.56 μM) with minimal cytotoxicity. It also inhibits SARS-CoV-2 and multiple 2 endemic, epide
More description
DC33571 CAY10566 Featured
CAY10566 is a potent and selective inhibitor of SCD1 that demonstrates IC50 values of 4.5 and 26 nM in mouse and human enzymatic assays, respectively.
More description
DC32353 Cenicriviroc Mesylate Featured
Cenicriviroc, also known as TAK-652 and TBR-652, is an experimental drug candidate for the treatment of HIV infection. It is being developed by Takeda Pharmaceutical and Tobira Therapeutics. Cenicriviroc is an inhibitor of CCR2 and CCR5 receptors, allowi
More description
DC26133 Camostat mesylate Featured
Camostat mesylate is a synthetic, orally bioavailable is a serine protease inhibitor. Used for the treatment of chronic pancreatitis. It attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity.
More description
DC7311 CC-930(Tanzisertib) Featured
CC-930(Tanzisertib) is a selective and potent JNK1/JNK2/JNK3(IC50=61/7/6 nM) inhibitor and is currently under clinical development for fibrotic and infammatory indications.
More description
DC10574 CID-25014542
CID-25014542 is novel inhibitor of Raf kinases.
More description
DC9488 Cilengitide Featured
Cilengitide (EMD 121974; NSC 707544) is a potent integrin inhibitor for αvβ3 and αvβ5 integrin with IC50 of 4.1 nM and 79 nM, respectively; ~10-fold selectivity against gpIIbIIIa.
More description
DC7602 DBeQ Featured
DBeQ is a selective, potent, reversible, and ATP-competitive p97 inhibitor with IC50 of 1.5 μM.
More description
DC8826 DB07268 Featured
DB07268 is a potent and selective JNK1 inhibitor with an IC50 value of 9 nM.
More description
DC3140 Dasatinib monohydrate Featured
Dasatinib is an orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases.
More description
DC7395 Dapivirine Featured
Dapivirine(TMC 120, TMC 120 R147681) is a NNRTI for HIV reverse transcriptase with IC50 of 24 nM, inhibits a broad panel of HIV-1 isolates from different classes, inclucing a wide range of NNRTI-resistant isolates.
More description
DC9259 DAA1106 Featured
DAA1106 is a potent and selective ligand for peripheral benzodiazepine receptors, in mitochondrial fractions of the rat brain.
More description
DC20219 D159687 Featured
D159687 is a selective negative allosteric modulator (NAM) of PDE4D.
More description
DC7734 CZC24832 Featured
CZC24832 is the first selective PI3Kγinhibitor with IC50 of 27 nM, with 10-fold selectivity over PI3Kβ and >100-fold selectivity over PI3Kα and PI3Kδ.
More description
DCAPI1295 Cytidine

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X